Neovasc designs and develops novel medical devices to address unmet clinical needs in vascular intervention. From procedural enhancements to novel therapies, we strive to benefit medical practice by making patient care faster, easier and more effective.
We provide distinctive solutions for interventional cardiologists, radiologists and vascular surgeons. Our products are intended to improve outcomes from balloon angioplasty, stent insertion and related procedures, and vascular tissue repair.
Our technologies are designed to offer improvements to current practice patterns, making lives easier for both doctor and patient. In some cases, our products represent new treatment options where none exists.
Neovasc was formed on July 1, 2008. Canadian device firm Medical Ventures Corp. acquired two Israeli development-stage device companies, Neovasc Medical Ltd. and B-Balloon Ltd.
Investor contacts
Investors-USA
GendelLindheim BioCom Partners
Barbara Lindheim
Email: blindheim@biocompartners.com
Phone: 212.918.4650
Investors-Canada
Chris Clark, CFO
Email: investors@neovasc.com
Phone: 604.270.4344 ext.113
